Category: Corporate Announcement

Announcement DSIR

Statement of Deviation or Variation under regulation 32 of SEBI(LODR) Regulations, 2015 for the quarter ended on March 31, 2023

Statement of Deviation or Variation under regulation 32 of SEBI(LODR) Regulations, 2015 for the quarter ended on December 31, 2021

Intimation Letter – submission advertisement publication dated 18th January 2019

Meeting with strategic global team of Ferring Pharmaceutical

Change in Chief financial officer

Intimation Letter under regulation 30 of SEBI (LODR) Regulations, 2015 , dated 17th January 2019

Sakar_Interaction_with_Investor_14th November 2022

Statement of Deviation or Variation under regulation 32 of SEBI(LODR) Regulations, 2015 for the quarter ended on September 30, 2021

Intimation Letter under regulation 30 of SEBI (LODR) Regulations, 2015 for submission of advertisement publication